Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.

Mol Neurodegener · 2010 · PMC2823744 · PMID 20205790

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

The associations between NYGGF4 levels and disease progression all demonstrated highly significant linear trends (F 1,95 = 17.425, p < 0.01 for CDR score, F 1,85 = 25.053, p < 0.001 for Braak stage, and F 1,96 = 13.102, p < 0.001 for plaque density).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.